Bruno is Founder, General Manager & Chief Scientist at NEUROSERVICE. Trained as a biochemist, neurophysiologist and pharmacologist, Bruno has more than 25 years of experience in electrophysiology (Patch-Clamp and Multi-Electrode Arrays) and receptor pharmacology.

Throughout a 6 year period, as Head of Pharmacology & Toxicology at TROPHOS (a French biotech), he enriched his experience in Drug Discovery programs targeting Central Nervous System pathologies. He is the co-author of 2 patented compounds that have been brought to Phase II in less than 5 years (for CNS and cardio-vascular diseases).

Bruno has supervised the development and the industrialization of many electrophysiological-based assays for CNS Drug Discovery, propelling Neuroservice to the status as the world-leading company in its field.

He attended the Ecole Normale Supérieure (Cachan) and received a PhD in Biochemistry and Neurosciences from the University of Montpellier (France). He was a postdoctoral fellow in the laboratory of Daniel Bertrand at the University of Geneva (Switzerland).